Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When a stock beats estimates but slides after hours, it creates a nagging question for investors. Here’s a clear, pra...
Global Payments stunned the market with a strong earnings beat and optimistic guidance, triggering a sharp stock move...
As Omnicom wraps up the 2025 fiscal year, investors want clarity on growth, margins, and capital allocation. This gui...
Investors are watching Nextdoor's 2025 earnings closely as the Q4 results shed light on monetization of local communi...
As Bausch Health prepares its Q4 2025 results, investors want clarity on margins, debt, and the pipeline. This guide ...
Netflix shares have pulled back from their peak, leaving many investors wondering if the dip represents a buying oppo...
HF Sinclair delivered a solid earnings beat, but shares fell sharply after leadership news. This article breaks down ...
As Herbalife wraps up 2025, investors seek clarity on growth, margins, and the path ahead. This article breaks down w...
Retirement income from Social Security isn’t a one-size-fits-all number. This deep dive explains what the average ret...
CubeSmart sits in a crowded self-storage field. This guide breaks down the key indicators I watch to assess whether C...
The 2026 software stock sell-off has traders buzzing, even as many companies post solid results. Is AI disruption fea...